Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients | MicrobiomeTrials← Back to trialsNCT07728318
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-08-12Est. Completion: 2027-01-12
Enrollment target: 52 participants Other microbiome trials you might be interested in
Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)OverweightMetabolic Syndrome
The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control a…
Almaty, KazakhstanEst. completion Nov 2026
Atherosclerotic Cardiovascular DiseaseOverweightObesity
The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as …
Daphne, United StatesEst. completion Jun 30, 2028